Condizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 89,74
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 96 pages. 8.66x5.91x0.22 inches. In Stock.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 115,14
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 49,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Obese and morbidly obese patients are a growing group of individuals worldwide that generates immense problems to society. They undergo various interventions that require anesthesia and/or analgesia. Despite their healthy look, these individuals are graded at high ASA physical status, mainly because of their impaired respiratory and cardiovascular conditions, and the metabolic changes their body undergo. Opioids are drugs ubiquitously used for perioperative analgesia. Their use has recently reached a frightening condition worldwide. Multimodal analgesia regimens have been recommended as a perioperative standard care, particularly for the obese. These regimens combine opioids with non-opioid compounds that augment the formers' analgesic potencies. Such protocols provide superior pain relief at rest, movement, or on effort, while reducing opioid consumption and their concerned adverse effects. The most important IV adjuvant currently employed is ketamine that sees resurgence among physicians from diverse medical specialties and for variable pain conditions. This review will summarize obese patients' perioperative drawbacks, will illustrate ketamine's neuropharmacology. 96 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 77,75
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 79,49
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Da: moluna, Greven, Germania
EUR 41,71
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Weinbroum Avi AProf. Avi Weinbroum, anesthesiologist and pain consultant, ran for 3 decades the PACU at the Tel Aviv Medical Center. As full professor and head of the Department of Anesthesia at the Tel Aviv University Medical School.
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 49,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Obese and morbidly obese patients are a growing group of individuals worldwide that generates immense problems to society. They undergo various interventions that require anesthesia and/or analgesia. Despite their healthy look, these individuals are graded at high ASA physical status, mainly because of their impaired respiratory and cardiovascular conditions, and the metabolic changes their body undergo. Opioids are drugs ubiquitously used for perioperative analgesia. Their use has recently reached a frightening condition worldwide. Multimodal analgesia regimens have been recommended as a perioperative standard care, particularly for the obese. These regimens combine opioids with non-opioid compounds that augment the formers' analgesic potencies. Such protocols provide superior pain relief at rest, movement, or on effort, while reducing opioid consumption and their concerned adverse effects. The most important IV adjuvant currently employed is ketamine that sees resurgence among physicians from diverse medical specialties and for variable pain conditions. This review will summarize obese patients' perioperative drawbacks, will illustrate ketamine's neuropharmacology.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 96 pp. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 50,50
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Obese and morbidly obese patients are a growing group of individuals worldwide that generates immense problems to society. They undergo various interventions that require anesthesia and/or analgesia. Despite their healthy look, these individuals are graded at high ASA physical status, mainly because of their impaired respiratory and cardiovascular conditions, and the metabolic changes their body undergo. Opioids are drugs ubiquitously used for perioperative analgesia. Their use has recently reached a frightening condition worldwide. Multimodal analgesia regimens have been recommended as a perioperative standard care, particularly for the obese. These regimens combine opioids with non-opioid compounds that augment the formers' analgesic potencies. Such protocols provide superior pain relief at rest, movement, or on effort, while reducing opioid consumption and their concerned adverse effects. The most important IV adjuvant currently employed is ketamine that sees resurgence among physicians from diverse medical specialties and for variable pain conditions. This review will summarize obese patients' perioperative drawbacks, will illustrate ketamine's neuropharmacology.